Global Peptide-based Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
LPI (LP Information)' newest research report, the “Peptide-based Drug Industry Forecast” looks at past sales and reviews total world Peptide-based Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide-based Drug sales for 2023 through 2029. With Peptide-based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide-based Drug industry.
This Insight Report provides a comprehensive analysis of the global Peptide-based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide-based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide-based Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide-based Drug.
The global Peptide-based Drug market size is projected to grow from US$ 31480 million in 2022 to US$ 58960 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.
United States market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peptide-based Drug players cover Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide-based Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
LPI (LP Information)' newest research report, the “Peptide-based Drug Industry Forecast” looks at past sales and reviews total world Peptide-based Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide-based Drug sales for 2023 through 2029. With Peptide-based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide-based Drug industry.
This Insight Report provides a comprehensive analysis of the global Peptide-based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide-based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide-based Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide-based Drug.
The global Peptide-based Drug market size is projected to grow from US$ 31480 million in 2022 to US$ 58960 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.
United States market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peptide-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peptide-based Drug players cover Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide-based Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Injection
- Oral
- Other
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Teva
- Novo Nordisk
- Takeda
- Eli Lilly
- AstraZeneca
- Novartis
- AbbVie
- Ipsen
- Ferring
- Merck
- The Medicines
- J & J
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide-based Drug Market Size 2018-2029
2.1.2 Peptide-based Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peptide-based Drug Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.3 Peptide-based Drug Market Size by Type
2.3.1 Peptide-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peptide-based Drug Market Size Market Share by Type (2018-2023)
2.4 Peptide-based Drug Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide-based Drug Market Size by Application
2.5.1 Peptide-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peptide-based Drug Market Size Market Share by Application (2018-2023)
3 PEPTIDE-BASED DRUG MARKET SIZE BY PLAYER
3.1 Peptide-based Drug Market Size Market Share by Players
3.1.1 Global Peptide-based Drug Revenue by Players (2018-2023)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Peptide-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE-BASED DRUG BY REGIONS
4.1 Peptide-based Drug Market Size by Regions (2018-2023)
4.2 Americas Peptide-based Drug Market Size Growth (2018-2023)
4.3 APAC Peptide-based Drug Market Size Growth (2018-2023)
4.4 Europe Peptide-based Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Peptide-based Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peptide-based Drug Market Size by Country (2018-2023)
5.2 Americas Peptide-based Drug Market Size by Type (2018-2023)
5.3 Americas Peptide-based Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide-based Drug Market Size by Region (2018-2023)
6.2 APAC Peptide-based Drug Market Size by Type (2018-2023)
6.3 APAC Peptide-based Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide-based Drug by Country (2018-2023)
7.2 Europe Peptide-based Drug Market Size by Type (2018-2023)
7.3 Europe Peptide-based Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide-based Drug by Region (2018-2023)
8.2 Middle East & Africa Peptide-based Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Peptide-based Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE-BASED DRUG MARKET FORECAST
10.1 Global Peptide-based Drug Forecast by Regions (2024-2029)
10.1.1 Global Peptide-based Drug Forecast by Regions (2024-2029)
10.1.2 Americas Peptide-based Drug Forecast
10.1.3 APAC Peptide-based Drug Forecast
10.1.4 Europe Peptide-based Drug Forecast
10.1.5 Middle East & Africa Peptide-based Drug Forecast
10.2 Americas Peptide-based Drug Forecast by Country (2024-2029)
10.2.1 United States Peptide-based Drug Market Forecast
10.2.2 Canada Peptide-based Drug Market Forecast
10.2.3 Mexico Peptide-based Drug Market Forecast
10.2.4 Brazil Peptide-based Drug Market Forecast
10.3 APAC Peptide-based Drug Forecast by Region (2024-2029)
10.3.1 China Peptide-based Drug Market Forecast
10.3.2 Japan Peptide-based Drug Market Forecast
10.3.3 Korea Peptide-based Drug Market Forecast
10.3.4 Southeast Asia Peptide-based Drug Market Forecast
10.3.5 India Peptide-based Drug Market Forecast
10.3.6 Australia Peptide-based Drug Market Forecast
10.4 Europe Peptide-based Drug Forecast by Country (2024-2029)
10.4.1 Germany Peptide-based Drug Market Forecast
10.4.2 France Peptide-based Drug Market Forecast
10.4.3 UK Peptide-based Drug Market Forecast
10.4.4 Italy Peptide-based Drug Market Forecast
10.4.5 Russia Peptide-based Drug Market Forecast
10.5 Middle East & Africa Peptide-based Drug Forecast by Region (2024-2029)
10.5.1 Egypt Peptide-based Drug Market Forecast
10.5.2 South Africa Peptide-based Drug Market Forecast
10.5.3 Israel Peptide-based Drug Market Forecast
10.5.4 Turkey Peptide-based Drug Market Forecast
10.5.5 GCC Countries Peptide-based Drug Market Forecast
10.6 Global Peptide-based Drug Forecast by Type (2024-2029)
10.7 Global Peptide-based Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide-based Drug Product Offered
11.1.3 Sanofi Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide-based Drug Product Offered
11.2.3 Teva Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide-based Drug Product Offered
11.3.3 Novo Nordisk Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide-based Drug Product Offered
11.4.3 Takeda Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide-based Drug Product Offered
11.5.3 Eli Lilly Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide-based Drug Product Offered
11.6.3 AstraZeneca Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide-based Drug Product Offered
11.7.3 Novartis Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide-based Drug Product Offered
11.8.3 AbbVie Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide-based Drug Product Offered
11.9.3 Ipsen Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide-based Drug Product Offered
11.10.3 Ferring Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide-based Drug Product Offered
11.11.3 Merck Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide-based Drug Product Offered
11.12.3 The Medicines Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide-based Drug Product Offered
11.13.3 J & J Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide-based Drug Market Size 2018-2029
2.1.2 Peptide-based Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peptide-based Drug Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.3 Peptide-based Drug Market Size by Type
2.3.1 Peptide-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peptide-based Drug Market Size Market Share by Type (2018-2023)
2.4 Peptide-based Drug Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Peptide-based Drug Market Size by Application
2.5.1 Peptide-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peptide-based Drug Market Size Market Share by Application (2018-2023)
3 PEPTIDE-BASED DRUG MARKET SIZE BY PLAYER
3.1 Peptide-based Drug Market Size Market Share by Players
3.1.1 Global Peptide-based Drug Revenue by Players (2018-2023)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Peptide-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE-BASED DRUG BY REGIONS
4.1 Peptide-based Drug Market Size by Regions (2018-2023)
4.2 Americas Peptide-based Drug Market Size Growth (2018-2023)
4.3 APAC Peptide-based Drug Market Size Growth (2018-2023)
4.4 Europe Peptide-based Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Peptide-based Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peptide-based Drug Market Size by Country (2018-2023)
5.2 Americas Peptide-based Drug Market Size by Type (2018-2023)
5.3 Americas Peptide-based Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide-based Drug Market Size by Region (2018-2023)
6.2 APAC Peptide-based Drug Market Size by Type (2018-2023)
6.3 APAC Peptide-based Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide-based Drug by Country (2018-2023)
7.2 Europe Peptide-based Drug Market Size by Type (2018-2023)
7.3 Europe Peptide-based Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide-based Drug by Region (2018-2023)
8.2 Middle East & Africa Peptide-based Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Peptide-based Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE-BASED DRUG MARKET FORECAST
10.1 Global Peptide-based Drug Forecast by Regions (2024-2029)
10.1.1 Global Peptide-based Drug Forecast by Regions (2024-2029)
10.1.2 Americas Peptide-based Drug Forecast
10.1.3 APAC Peptide-based Drug Forecast
10.1.4 Europe Peptide-based Drug Forecast
10.1.5 Middle East & Africa Peptide-based Drug Forecast
10.2 Americas Peptide-based Drug Forecast by Country (2024-2029)
10.2.1 United States Peptide-based Drug Market Forecast
10.2.2 Canada Peptide-based Drug Market Forecast
10.2.3 Mexico Peptide-based Drug Market Forecast
10.2.4 Brazil Peptide-based Drug Market Forecast
10.3 APAC Peptide-based Drug Forecast by Region (2024-2029)
10.3.1 China Peptide-based Drug Market Forecast
10.3.2 Japan Peptide-based Drug Market Forecast
10.3.3 Korea Peptide-based Drug Market Forecast
10.3.4 Southeast Asia Peptide-based Drug Market Forecast
10.3.5 India Peptide-based Drug Market Forecast
10.3.6 Australia Peptide-based Drug Market Forecast
10.4 Europe Peptide-based Drug Forecast by Country (2024-2029)
10.4.1 Germany Peptide-based Drug Market Forecast
10.4.2 France Peptide-based Drug Market Forecast
10.4.3 UK Peptide-based Drug Market Forecast
10.4.4 Italy Peptide-based Drug Market Forecast
10.4.5 Russia Peptide-based Drug Market Forecast
10.5 Middle East & Africa Peptide-based Drug Forecast by Region (2024-2029)
10.5.1 Egypt Peptide-based Drug Market Forecast
10.5.2 South Africa Peptide-based Drug Market Forecast
10.5.3 Israel Peptide-based Drug Market Forecast
10.5.4 Turkey Peptide-based Drug Market Forecast
10.5.5 GCC Countries Peptide-based Drug Market Forecast
10.6 Global Peptide-based Drug Forecast by Type (2024-2029)
10.7 Global Peptide-based Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide-based Drug Product Offered
11.1.3 Sanofi Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide-based Drug Product Offered
11.2.3 Teva Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide-based Drug Product Offered
11.3.3 Novo Nordisk Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide-based Drug Product Offered
11.4.3 Takeda Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide-based Drug Product Offered
11.5.3 Eli Lilly Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide-based Drug Product Offered
11.6.3 AstraZeneca Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide-based Drug Product Offered
11.7.3 Novartis Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide-based Drug Product Offered
11.8.3 AbbVie Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide-based Drug Product Offered
11.9.3 Ipsen Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide-based Drug Product Offered
11.10.3 Ferring Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide-based Drug Product Offered
11.11.3 Merck Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide-based Drug Product Offered
11.12.3 The Medicines Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide-based Drug Product Offered
11.13.3 J & J Peptide-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide-based Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Major Players of Other
Table 5. Peptide-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 8. Peptide-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Peptide-based Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Peptide-based Drug Revenue Market Share by Player (2018-2023)
Table 13. Peptide-based Drug Key Players Head office and Products Offered
Table 14. Peptide-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide-based Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Peptide-based Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Peptide-based Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Peptide-based Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Peptide-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Peptide-based Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Peptide-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Peptide-based Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Peptide-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Peptide-based Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Peptide-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Peptide-based Drug
Table 46. Key Market Challenges & Risks of Peptide-based Drug
Table 47. Key Industry Trends of Peptide-based Drug
Table 48. Global Peptide-based Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Peptide-based Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Peptide-based Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Peptide-based Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Sanofi Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 53. Sanofi Peptide-based Drug Product Offered
Table 54. Sanofi Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Teva Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 58. Teva Peptide-based Drug Product Offered
Table 59. Teva Main Business
Table 60. Teva Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Teva Latest Developments
Table 62. Novo Nordisk Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 63. Novo Nordisk Peptide-based Drug Product Offered
Table 64. Novo Nordisk Main Business
Table 65. Novo Nordisk Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Novo Nordisk Latest Developments
Table 67. Takeda Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 68. Takeda Peptide-based Drug Product Offered
Table 69. Takeda Main Business
Table 70. Takeda Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Takeda Latest Developments
Table 72. Eli Lilly Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 73. Eli Lilly Peptide-based Drug Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Eli Lilly Latest Developments
Table 77. AstraZeneca Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 78. AstraZeneca Peptide-based Drug Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. AstraZeneca Latest Developments
Table 82. Novartis Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 83. Novartis Peptide-based Drug Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Novartis Latest Developments
Table 87. AbbVie Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 88. AbbVie Peptide-based Drug Product Offered
Table 89. AbbVie Main Business
Table 90. AbbVie Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. AbbVie Latest Developments
Table 92. Ipsen Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 93. Ipsen Peptide-based Drug Product Offered
Table 94. Ipsen Main Business
Table 95. Ipsen Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Ipsen Latest Developments
Table 97. Ferring Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 98. Ferring Peptide-based Drug Product Offered
Table 99. Ferring Main Business
Table 100. Ferring Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Ferring Latest Developments
Table 102. Merck Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 103. Merck Peptide-based Drug Product Offered
Table 104. Merck Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. The Medicines Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 108. The Medicines Peptide-based Drug Product Offered
Table 109. The Medicines Main Business
Table 110. The Medicines Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. The Medicines Latest Developments
Table 112. J & J Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 113. J & J Peptide-based Drug Product Offered
Table 114. J & J Main Business
Table 115. J & J Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. J & J Latest Developments
Table 1. Peptide-based Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Major Players of Other
Table 5. Peptide-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 8. Peptide-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Peptide-based Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Peptide-based Drug Revenue Market Share by Player (2018-2023)
Table 13. Peptide-based Drug Key Players Head office and Products Offered
Table 14. Peptide-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide-based Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Peptide-based Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Peptide-based Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Peptide-based Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Peptide-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Peptide-based Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Peptide-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Peptide-based Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Peptide-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Peptide-based Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Peptide-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Peptide-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Peptide-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Peptide-based Drug
Table 46. Key Market Challenges & Risks of Peptide-based Drug
Table 47. Key Industry Trends of Peptide-based Drug
Table 48. Global Peptide-based Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Peptide-based Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Peptide-based Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Peptide-based Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Sanofi Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 53. Sanofi Peptide-based Drug Product Offered
Table 54. Sanofi Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Teva Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 58. Teva Peptide-based Drug Product Offered
Table 59. Teva Main Business
Table 60. Teva Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Teva Latest Developments
Table 62. Novo Nordisk Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 63. Novo Nordisk Peptide-based Drug Product Offered
Table 64. Novo Nordisk Main Business
Table 65. Novo Nordisk Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Novo Nordisk Latest Developments
Table 67. Takeda Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 68. Takeda Peptide-based Drug Product Offered
Table 69. Takeda Main Business
Table 70. Takeda Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Takeda Latest Developments
Table 72. Eli Lilly Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 73. Eli Lilly Peptide-based Drug Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Eli Lilly Latest Developments
Table 77. AstraZeneca Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 78. AstraZeneca Peptide-based Drug Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. AstraZeneca Latest Developments
Table 82. Novartis Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 83. Novartis Peptide-based Drug Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Novartis Latest Developments
Table 87. AbbVie Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 88. AbbVie Peptide-based Drug Product Offered
Table 89. AbbVie Main Business
Table 90. AbbVie Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. AbbVie Latest Developments
Table 92. Ipsen Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 93. Ipsen Peptide-based Drug Product Offered
Table 94. Ipsen Main Business
Table 95. Ipsen Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Ipsen Latest Developments
Table 97. Ferring Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 98. Ferring Peptide-based Drug Product Offered
Table 99. Ferring Main Business
Table 100. Ferring Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Ferring Latest Developments
Table 102. Merck Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 103. Merck Peptide-based Drug Product Offered
Table 104. Merck Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. The Medicines Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 108. The Medicines Peptide-based Drug Product Offered
Table 109. The Medicines Main Business
Table 110. The Medicines Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. The Medicines Latest Developments
Table 112. J & J Details, Company Type, Peptide-based Drug Area Served and Its Competitors
Table 113. J & J Peptide-based Drug Product Offered
Table 114. J & J Main Business
Table 115. J & J Peptide-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. J & J Latest Developments
LIST OF FIGURES
Figure 1. Peptide-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide-based Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peptide-based Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peptide-based Drug Sales Market Share by Country/Region (2022)
Figure 8. Peptide-based Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peptide-based Drug Market Size Market Share by Type in 2022
Figure 10. Peptide-based Drug in Cancer
Figure 11. Global Peptide-based Drug Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Peptide-based Drug in Metabolic Disorders
Figure 13. Global Peptide-based Drug Market: Metabolic Disorders (2018-2023) & ($ Millions)
Figure 14. Peptide-based Drug in Central Nervous System
Figure 15. Global Peptide-based Drug Market: Central Nervous System (2018-2023) & ($ Millions)
Figure 16. Peptide-based Drug in Other
Figure 17. Global Peptide-based Drug Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Peptide-based Drug Market Size Market Share by Application in 2022
Figure 19. Global Peptide-based Drug Revenue Market Share by Player in 2022
Figure 20. Global Peptide-based Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Peptide-based Drug Value Market Share by Country in 2022
Figure 26. United States Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Peptide-based Drug Market Size Market Share by Region in 2022
Figure 31. APAC Peptide-based Drug Market Size Market Share by Type in 2022
Figure 32. APAC Peptide-based Drug Market Size Market Share by Application in 2022
Figure 33. China Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Peptide-based Drug Market Size Market Share by Country in 2022
Figure 40. Europe Peptide-based Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Peptide-based Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Peptide-based Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Peptide-based Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Peptide-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide-based Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peptide-based Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peptide-based Drug Sales Market Share by Country/Region (2022)
Figure 8. Peptide-based Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peptide-based Drug Market Size Market Share by Type in 2022
Figure 10. Peptide-based Drug in Cancer
Figure 11. Global Peptide-based Drug Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Peptide-based Drug in Metabolic Disorders
Figure 13. Global Peptide-based Drug Market: Metabolic Disorders (2018-2023) & ($ Millions)
Figure 14. Peptide-based Drug in Central Nervous System
Figure 15. Global Peptide-based Drug Market: Central Nervous System (2018-2023) & ($ Millions)
Figure 16. Peptide-based Drug in Other
Figure 17. Global Peptide-based Drug Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Peptide-based Drug Market Size Market Share by Application in 2022
Figure 19. Global Peptide-based Drug Revenue Market Share by Player in 2022
Figure 20. Global Peptide-based Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Peptide-based Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Peptide-based Drug Value Market Share by Country in 2022
Figure 26. United States Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Peptide-based Drug Market Size Market Share by Region in 2022
Figure 31. APAC Peptide-based Drug Market Size Market Share by Type in 2022
Figure 32. APAC Peptide-based Drug Market Size Market Share by Application in 2022
Figure 33. China Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Peptide-based Drug Market Size Market Share by Country in 2022
Figure 40. Europe Peptide-based Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Peptide-based Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Peptide-based Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Peptide-based Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Peptide-based Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Peptide-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Peptide-based Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Peptide-based Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Peptide-based Drug Market Size Market Share Forecast by Application (2024-2029)
